Read Young Innovator profile on Dr. Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19.
Young Innovator Program Inventor Spotlight: Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19. Diana ...
Read More
Read More
Congratulations to graduate student Matthew Boudreau for being awarded a prestigious fellowship from NCI!
Matthew Boudreau, a chemistry PhD candidate in the CCIL Deputy Director Paul Hergenrother’s lab, has been awarded the prestigious F99/K00 grant ...
Read More
Read More
A compound for breast cancer discovered and developed in the Hergenrother and Shapiro labs has been licensed to Bayer
Paul Hergenrother helps discover cancer compound now in licensing deal. Researchers affiliated with the Cancer Center at Illinois discovered a ...
Read More
Read More
Congratulations to Riley Svec
Riley Svec was awarded a position on the NIH Chemistry-Biology Interface Training Grant. He was an Advanced Graduate Student speaker ...
Read More
Read More
Congratulations to Kristen Muñoz for being awarded a position on the NIH Chemistry-Biology Interface Training Grant!
Gram-negative bacteria have emerged that are resistant to most antibiotics, a troubling trend since a new class of antibiotics for ...
Read More
Read More
Congratulations to former graduate student Dr. Michelle Richter
Dr. Richter received the ACS Scarborough Award for Graduate Excellence in Medicinal Chemistry! See mention of Michelle in Boston Globe ...
Read More
Read More
Congratulations to two students for receiving NSF Research Fellowships
We congratulate graduate student Martin Garcia Chavez and undergraduate Amanda Cowfer for being awarded NSF Research Fellowships! ...
Read More
Read More
See story on Pretzel, a pet dog with glioma successfully treated with PAC-1.
Clinical trials on companion animals diagnosed with cancer have brought new hope to their owners—and new data for a cutting-edge ...
Read More
Read More
A Phase 1b clinical trial of PAC-1 for glioblastoma patients has begun
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with ...
Read More
Read More
eNTRyway is LIVE!
eNTRyway is our web app for predicting compound accumulation in Gram-negative bacteria. It predicts the likelihood of a small-molecule to ...
Read More
Read More
Congratulations to Dr. Sarah Tasker for being awarded a postdoctoral fellowship
We congratulate Dr. Sarah Tasker on being awarded a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation ...
Read More
Read More
The FDA grants Orphan Drug Designation to PAC-1!
Human trials of cancer drug PAC-1 continue with new investment. University of Illinois chemistry professor Paul Hergenrother, right, and veterinary ...
Read More
Read More
PAC-1 shows efficacy in dog trial
Chasing cancer with dogs — Treating canine cancers is helping researchers learn more about human forms of the disease. Thunder is ...
Read More
Read More
The Phase 1 clinical trial of PAC-1 in human cancer patients has begun!
See listing on clinicaltrials.gov, listen to the interview, watch a PBS documentary about comparative oncology including PAC-1, and watch the ...
Read More
Read More
Congratulations to Sarah Perlmutter
We congratulate Sarah Perlmutter for receiving a NSF Predoctoral Graduate Research Fellowship! ...
Read More
Read More
